ACTRN12617001173381招募中未知
A feasibility study of a multi-centre trial of a change in practice (introduction of an Advanced Recovery Room care unit) with measurement of in-hospital and post discharge quality and cost.
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 480
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1.)Patient predicted with 1 to 4% 30-day mortality based on ACS NSQIP surgical risk scoring (available at http://riskcalculator.facs.org/RiskCalculator/)
- •2.)Scheduled to undergo elective or emergency surgery requiring at least 3 days stay in hospital.
- •3.)Scheduled for postoperative care in the recovery room and then a general surgical ward
- •4.)Available for follow up at 90 days
排除标准
- •1.)Cardiac surgery
- •2.)Planned admission to ICU/HDU postoperatively
研究者
相似试验
已完成
不适用
A feasibility study of a multi-centre randomised controlled trial of early versus late surgery for intermittent distance exotropiaSurgery: ExotropiaEye DiseasesExotropiaISRCTN04267774Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
已完成
不适用
CONSERVE studyCancerISRCTN23852951ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)74
招募中
不适用
The multicenter clinical trial to investigate the safety and efficacy of FOLFOX therapy in gastrointestinal cancer patients undergoing hemodialysisgastrointestinal cancerJPRN-UMIN000033322Kyoto University15
招募中
不适用
The feasibility study of FOLFOX therapy in gastrointestinal cancer patients undergoing hemodialysisEsophageal cancer, gastric cancer, small bowel cancer, colorectal cancerJPRN-jRCTs051190120Manabu Muto15
进行中（未招募）
1 期
A randomised, multi-centre feasibility trial in AL Amyloidosis, comparing CTD with SCT in patients with low risk of Treatment Related Mortality and CTD with Mel-Dex in patients in whom SCT would not be considered appropriate as first line therapy - UK Amyloidosis Treatment Trial (UKATT)EUCTR2006-006395-37-GBJoint UCLH and UCL Biomedical Research Unit48